Showing 1 - 10 of 65
Persistent link: https://www.econbiz.de/10010281343
There are few studies investigating the consequences of osteoporotic (low bone density) fractures in terms of costs and health outcomes. The purpose of this Swedish pilot study is to assess the costs and quality of life related to fractures of the hip, spine, wrist and shoulder and further to...
Persistent link: https://www.econbiz.de/10010281361
The cost-effectiveness of hormone replacement therapy (HRT) based on a societal perspective is reassessed based on new medical evidence found in the Women's Health Initiative (WHI). Within a model framework using an individual state transition model the cost-effectiveness of 50-60 year old women...
Persistent link: https://www.econbiz.de/10010281446
This paper deals with the question how to model health effects after the cessation of a randomised controlled trial (RCT). Using clinical trial data on severe congestive heart failure patients we illustrate how survival beyond the cessation of a RCT can be predicted based on parametric survival...
Persistent link: https://www.econbiz.de/10010281459
There are few studies investigating the consequences of osteoporotic (low bone density) fractures in terms of costs and health outcomes. The purpose of this Swedish pilot study is to assess the costs and quality of life related to fractures of the hip, spine, wrist and shoulder and further to...
Persistent link: https://www.econbiz.de/10005771160
In this study we report an attempt to measure the value adult Swedes impute to an increased survival probability at high ages. A rating scale between the worst possible quality of life (=1) and the best possible quality of life (=10) is used to indicate the quality of life a person expects to...
Persistent link: https://www.econbiz.de/10005190820
The average cesarean section rate in Sweden more than doubled during the 1970s, and amounted to 12-3 percent in 1983. After that, there was a steady-state for a couple of years and towards the end of the 80s even a small decrease, to 10.9 percent in 1990. In the early 90s, there was a slight...
Persistent link: https://www.econbiz.de/10005190830
SUMMARY <p> Treatment of multiple sclerosis (MS) has changed substantially during the past decade, as new biological disease-modifying treatments have been introduced in a field where only symptomatic pharmacological treatment had been available. The new treatments come at a high cost, between $...</p>
Persistent link: https://www.econbiz.de/10005190908
This paper shows that there exists a close relation between the net benefit and Fieller's methods for calculation of confidence intervals and performing hypothesis testing in cost-effectiveness analysis. The prices at which the net benefit confidence interval limits are equal to zero are...
Persistent link: https://www.econbiz.de/10005190911
This report presents a computer model for evaluating the cost-effectiveness (CE) of Hormone Replacement Therapy (HRT). The model is an extension of a previous model and includes also the risk of spine and wrist fracture. New Swedish data on risk of coronary heart disease and related mortality...
Persistent link: https://www.econbiz.de/10005423792